671 related articles for article (PubMed ID: 18978179)
21. Aquaporin expression is downregulated in a murine model of colitis and in patients with ulcerative colitis, Crohn's disease and infectious colitis.
Hardin JA; Wallace LE; Wong JF; O'Loughlin EV; Urbanski SJ; Gall DG; MacNaughton WK; Beck PL
Cell Tissue Res; 2004 Nov; 318(2):313-23. PubMed ID: 15338270
[TBL] [Abstract][Full Text] [Related]
22. Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats.
Tanaka F; Tominaga K; Ochi M; Tanigawa T; Watanabe T; Fujiwara Y; Ohta K; Oshitani N; Higuchi K; Arakawa T
Life Sci; 2008 Dec; 83(23-24):771-9. PubMed ID: 18950645
[TBL] [Abstract][Full Text] [Related]
23. Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis.
De Vry CG; Prasad S; Komuves L; Lorenzana C; Parham C; Le T; Adda S; Hoffman J; Kahoud N; Garlapati R; Shyamsundar R; Mai K; Zhang J; Muchamuel T; Dajee M; Schryver B; McEvoy LM; Ehrhardt RO
Gut; 2007 Apr; 56(4):524-33. PubMed ID: 16950831
[TBL] [Abstract][Full Text] [Related]
24. Arsenic trioxide reduces 2,4,6-trinitrobenzene sulfonic acid-induced murine colitis via nuclear factor-κB down-regulation and caspase-3 activation.
Singer M; Trugnan G; Chelbi-Alix MK
Innate Immun; 2011 Aug; 17(4):365-74. PubMed ID: 20693187
[TBL] [Abstract][Full Text] [Related]
25. A novel mTOR inhibitor is efficacious in a murine model of colitis.
Bhonde MR; Gupte RD; Dadarkar SD; Jadhav MG; Tannu AA; Bhatt P; Bhatia DR; Desai NK; Deore V; Yewalkar N; Vishwakarma RA; Sharma S; Kumar S; Dagia NM
Am J Physiol Gastrointest Liver Physiol; 2008 Dec; 295(6):G1237-45. PubMed ID: 18927209
[TBL] [Abstract][Full Text] [Related]
26. Dextran sulphate sodium induces acute colitis and alters hepatic function in hamsters.
Karlsson A; Jägervall A; Pettersson M; Andersson AK; Gillberg PG; Melgar S
Int Immunopharmacol; 2008 Jan; 8(1):20-7. PubMed ID: 18068096
[TBL] [Abstract][Full Text] [Related]
27. Thalidomide treatment reduces colon injury induced by experimental colitis.
Mazzon E; Muià C; Di Paola R; Genovese T; De Sarro A; Cuzzocrea S
Shock; 2005 Jun; 23(6):556-64. PubMed ID: 15897810
[TBL] [Abstract][Full Text] [Related]
28. The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis.
Tokuyama H; Ueha S; Kurachi M; Matsushima K; Moriyasu F; Blumberg RS; Kakimi K
Int Immunol; 2005 Aug; 17(8):1023-34. PubMed ID: 16000328
[TBL] [Abstract][Full Text] [Related]
29. Selective targeting of activated T cells in chronic intestinal inflammation.
Weigmann B; Neurath MF
Gut; 2009 Jun; 58(6):747-8. PubMed ID: 19433594
[No Abstract] [Full Text] [Related]
30. Efficacy of keratinocyte growth factor-2 in dextran sulfate sodium-induced murine colitis.
Miceli R; Hubert M; Santiago G; Yao DL; Coleman TA; Huddleston KA; Connolly K
J Pharmacol Exp Ther; 1999 Jul; 290(1):464-71. PubMed ID: 10381813
[TBL] [Abstract][Full Text] [Related]
31. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
Elinav E; Waks T; Eshhar Z
Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
[TBL] [Abstract][Full Text] [Related]
32. A novel design of targeted endocrine and cytokine therapy for breast cancer.
Zhang G; Li W; Holle L; Chen N; Chen WY
Clin Cancer Res; 2002 Apr; 8(4):1196-205. PubMed ID: 11948133
[TBL] [Abstract][Full Text] [Related]
33. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.
González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
Gastroenterology; 2009 Mar; 136(3):978-89. PubMed ID: 19135996
[TBL] [Abstract][Full Text] [Related]
34. Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis.
Schmidt N; Gonzalez E; Visekruna A; Kühl AA; Loddenkemper C; Mollenkopf H; Kaufmann SH; Steinhoff U; Joeris T
Gut; 2010 Jul; 59(7):896-906. PubMed ID: 20581238
[TBL] [Abstract][Full Text] [Related]
35. In vivo treatment with a nonapeptide thymic hormone, facteur thymique serique (FTS), ameliorates chronic colitis induced by dextran sulphate sodium in mice.
Sun X; Yamada H; Yoshihara K; Awaya A; Yoshikai Y
Int Immunopharmacol; 2007 Jul; 7(7):928-36. PubMed ID: 17499195
[TBL] [Abstract][Full Text] [Related]
36. Anti-inflammatory effects of methanol extract of Patrinia scabiosaefolia in mice with ulcerative colitis.
Cho EJ; Shin JS; Noh YS; Cho YW; Hong SJ; Park JH; Lee JY; Lee JY; Lee KT
J Ethnopharmacol; 2011 Jul; 136(3):428-35. PubMed ID: 20573566
[TBL] [Abstract][Full Text] [Related]
37. Hydrogen mediates suppression of colon inflammation induced by dextran sodium sulfate.
Kajiya M; Silva MJ; Sato K; Ouhara K; Kawai T
Biochem Biophys Res Commun; 2009 Aug; 386(1):11-5. PubMed ID: 19486890
[TBL] [Abstract][Full Text] [Related]
38. The opioid antagonist naltrexone improves murine inflammatory bowel disease.
Matters GL; Harms JF; McGovern C; Fitzpatrick L; Parikh A; Nilo N; Smith JP
J Immunotoxicol; 2008 Apr; 5(2):179-87. PubMed ID: 18569389
[TBL] [Abstract][Full Text] [Related]
39. Altered phenotype of dextran sulfate sodium colitis in interferon regulatory factor-1 knock-out mice.
Mannick EE; Cote RL; Schurr JR; Krowicka HS; Sloop GD; Zapata-Velandia A; Correa H; Ruiz B; Horswell R; Lentz JJ; Byrne P; Gastanaduy MM; Hornick CA; Liu Z
J Gastroenterol Hepatol; 2005 Mar; 20(3):371-80. PubMed ID: 15740479
[TBL] [Abstract][Full Text] [Related]
40. A role for proteinase-activated receptor-1 in inflammatory bowel diseases.
Vergnolle N; Cellars L; Mencarelli A; Rizzo G; Swaminathan S; Beck P; Steinhoff M; Andrade-Gordon P; Bunnett NW; Hollenberg MD; Wallace JL; Cirino G; Fiorucci S
J Clin Invest; 2004 Nov; 114(10):1444-56. PubMed ID: 15545995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]